Correlation Between SeqLL and Biodesix
Can any of the company-specific risk be diversified away by investing in both SeqLL and Biodesix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL and Biodesix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SeqLL Inc and Biodesix, you can compare the effects of market volatilities on SeqLL and Biodesix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL with a short position of Biodesix. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL and Biodesix.
Diversification Opportunities for SeqLL and Biodesix
Modest diversification
The 3 months correlation between SeqLL and Biodesix is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Inc and Biodesix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodesix and SeqLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Inc are associated (or correlated) with Biodesix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodesix has no effect on the direction of SeqLL i.e., SeqLL and Biodesix go up and down completely randomly.
Pair Corralation between SeqLL and Biodesix
If you would invest 39.00 in SeqLL Inc on September 4, 2024 and sell it today you would earn a total of 0.00 from holding SeqLL Inc or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
SeqLL Inc vs. Biodesix
Performance |
| Timeline |
| SeqLL Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Biodesix |
SeqLL and Biodesix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SeqLL and Biodesix
The main advantage of trading using opposite SeqLL and Biodesix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL position performs unexpectedly, Biodesix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodesix will offset losses from the drop in Biodesix's long position.| SeqLL vs. Agilent Technologies | SeqLL vs. Genetic Technologies | SeqLL vs. T2 Biosystms | SeqLL vs. iSpecimen |
| Biodesix vs. Aclaris Therapeutics | Biodesix vs. Castle Biosciences | Biodesix vs. Prenetics Global | Biodesix vs. DarioHealth Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |